Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UK’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.
Appears in 2 contracts
Samples: Loan and Security Agreement (Mesoblast LTD), Loan and Security Agreement (Mesoblast LTD)
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 of 20 May 2015 on insolvency proceedings (recast) on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl Replimune UK’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.
Appears in 1 contract
Samples: Loan and Security Agreement (Replimune Group, Inc.)
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UKto the extent applicable to Urovant England, Urovant England’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.
Appears in 1 contract
Samples: Loan and Security Agreement (Urovant Sciences Ltd.)
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UKAxovant England’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.
Appears in 1 contract
Samples: Loan and Security Agreement (Axovant Sciences Ltd.)
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UKU.K. Credit Party’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.
Appears in 1 contract
Samples: Credit Agreement (Handleman Co /Mi/)
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UKto the extent applicable to Dermavant England, Dermavant England’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.
Appears in 1 contract
Samples: Loan and Security Agreement (Dermavant Sciences LTD)
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UKU.K. Guarantor’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.
Appears in 1 contract
Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 of 20 May 2015 on insolvency proceedings (recast) on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl Replimune UK’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.. 5.16
Appears in 1 contract
Samples: Loan and Security Agreement (Replimune Group, Inc.)